ArticleJournal of hepatology2015

Hepatic dimethylarginine-dimethylaminohydrolase1 is reduced in cirrhosis and is a target for therapy in portal hypertension.

Rajeshwar P Mookerjee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.